Biotech Values

[iwfal]

. Whether BAX got the better of MNTA, MNTA got the better of BAX, or the deal was exactly fair in every respect is no longer of any great consequence to me as a MNTA investor.

I'll take that as concurrence that either MNTA got screwed or MNTA and BAX concur on fact that the Market share for mBio is going to be a lot lower than you believe. You are, of course, entitled to disagree with MNTA/BAX - but then that is an admission that MNTA goT screwed (contrary to what you asserted yesterday)